Lung Cancer EXAM 3 Flashcards

1
Q

What are the 3 mechanisms that cause abnormal cell proliferation/differentiation in lung cancer?

A
  1. Protooncogene acitvation
  2. Tumor suppressor gene inactivation
  3. Immune system evasion (PD-L1 expression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which Protoonco genes are commonly upregulated in lung cancer?

A

EGFR (NSCLC), KIT (SCLC)
-EGFR, ALK, BRAF, MET, RET, ROS1 mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most common cause of lung cancer?

A

Smoking (80% of lung cancer deaths)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the secondary causes of lung cancer?

A

secondhand smoke
asbestos
radon (old houses)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are common symptoms of a patient with lung cancer?

A

-Hemoptysis (coughing up blood)
-Cough, hoarseness !!! (most common)
-Dyspnea
-Blood-tinged or purulent sputum
-Chest, shoulder, or arm pain
-Wheezing, stridor
-Superior vena cava syndrome
-Dysphagia
-Pleural effusion, pneumonitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which test is used to screen for lung cancer? How often should it be performed?

A

low-dose CT scan

-done 3x yearly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which patient population is screened for lung cancer?

A

Adults 55-80 yoa who have 30year-pack history, and have smoked for at least the last 15 years

(if they have quit for 16 or more years they don’t qualify for screening)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which lung cancer type grows rapidly and which slowly?

A

rapidly: small-cell -> SMOKER

slowly: non-small-cell (80% of lung cancer)
-squamous -> SMOKER
-adenocarcinoma
-large cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which anticancer drug has lower efficacy in squamous cell lung cancer? Why?

A

Pemetrexed

squamous cell cancer has higher levels of Thymidylate synthetase enzymes (TS) -> greater resistance to the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why does histology (checking lung tissue) matter in lung cancer treatment?

A

to differentiate between squamous and adenocarcinoma

for squamous we don’t use pemetrexed bc of high expression of TS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which genetic mutations are associated with adenocarcinoma patients who are non-smokers?

A

-EGFR
-BRAF V600E
-ALK
-ROS1
-MET
-RET
-KRASG12C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the most important chemotherapy drugs for NSCLC and SCLC?

A

Cisplatin or Carboplatin + another chemotherapy drug + immunocheckpoint inhibitor

may use immune checkpoint inhibitor alone if PD-L1 is high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EGFR antagonists (especially TKIs) work well with which type of mutations?

A

EGFR (always ON) activating mutation
-Exon 19 deletion
-Exon 21 L858R mutation

Drugs: TKIs (-inib)
-Erlotinib
-afatinib
-gefitinib
-osimertinib (Tagrisso) !!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the unique toxicity of EGFR antagonists?

A

-Rash
-Diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which TKI has lower rates of diarrhea?

A

Osimertinib
bc it has a higher affinity for mutated EGFR and doesn’t affect healthy cells as much

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the brand name of Osimertinib?

17
Q

What are the 4 major counseling points for patients with an acne-like rash after lung cancer treatment?

A

-use non-irritating soap (no astringent or EtOH)
-avoid sun exposure, use sunscreen
-use non-irritating moisturizers
-refer to the doctor for severe lesions

18
Q

What are the treatment options for severe acne lesions?

A

topical corticosteroids
doxycycline

19
Q

What are the unique toxicities of immune checkpoint inhibitors (PD-1 monoclonal antibodies)?

Nivolumab and pembrolizumab

A

Immune-mediated: LEGS
Liver (increase in AST/ALT and bilirubin)
Endocrine (pituitary, thyroid, adrenal)
GI (diarrhea, colitis)
Skin (rash, dermatitis, vitiligo-killing of melanocytes)
also cardiac (myocarditis, pericarditis)

-treat with corticosteroids

20
Q

How are toxicities of immune checkpoints treated?

Nivolumab and pembrolizumab

A

corticosteroids: 1-2 mg/kg prednisone equivalent daily until symptoms improve

-adrenal insufficiency: hydrocortisone
-hypothyroidism: levothyroxine

21
Q

Which labs to check for PD-1 drugs?

A

-LFT, AST/ALT
-TSH (is elevated), sometimes T4
-cortisol levels to measure adrenal insufficiency

check every cycle (every 4 weeks)

22
Q

What is the Adjuvant treatment approach for early-stage NSCLC for a patient with Adenocarcinoma (large cell) if cure is the goal?

A

Cisplatin doublet (Cisplatin is more effective, also more toxic)

Cisplatin + Pemetrexed

23
Q

What is the Adjuvant treatment approach for early-stage NSCLC for a patient with Squamous cells if a cure is the goal?

A

Cisplatin doublet (Cisplatin is more effective, also more toxic)

Cisplatin + gemcitabin
Cisplatin + docetxal
Cisplatin + vinorelbine

24
Q

Which drug is used to prevent myelosuppression from pemetrexed?

A

Folic acid and Vitamin B12

for skin reaction: Dexamethasone

25
Q

Drug of choice for EGFR mutated NSCLC?
(palliative)

A

Osimertinib (Tagrisso)
(EGFR TKI)

26
Q

Drug of choice for NSCLC with ALK rearrangements?
(palliative)

A

Alectininb
(ALK TKI)

27
Q

Drug of choice for NSCLC with ROS1 rearrangements?
(palliative)

A

Crizotinib
(ROS1 TKI)

28
Q

Drug of choice for BRAF V600E mutated NSCLC?
(palliative)

A

Dabrafenib + trametinib
(BRAF TKI + MEK TKI)

29
Q

Drug of choice for NSCLC with other actionable mutations?
(palliative)

A

Selpercatinib
capmatinib
sotorasib

30
Q

Drug of choice for NSCLC with Non-squamous cells?
(palliative)
!!!

A

Non-squamous -> usually adenocarcinoma

Carboplatin + pemetrexed + immunotherapy

31
Q

Drug of choice for NSCLC with Squamous cells?
(palliative)

A

Carboplatin + paclitaxel + immunotherapy

32
Q

Drug of choice for NSCLC with high PD-L1 expression?
(palliative)

A

Pembrolizumab (PD-1 inhibitor)

33
Q

Drug option for patients who are bad candidates for cytotoxic agents (bad kidney or liver function)

A

go with immune inhibitors -> but more immune-related events

nevoliumab + ipilimumab

34
Q

Drug regimen for adenocarcinoma/large cell histology

A

Platinum/pemetrexed + IO (immunecheck inhibitor); or nivolumab + ipilimumab (CTLA-4 inhibitor)

35
Q

A patient has received carboplatin + paclitaxel + pembrolizumab. 4 days after cycle 2 she was admitted to the hospital with diarrhea and dehydration. How should this be managed?

A

probably immune-related:
L
E
GI (diarrhea, colitis)
S

IV fluids + steroids (methylprednisolone) 1mg/kg BID

36
Q

What is the most effective treatment for NSCLC?

A

Surgery
-most patients are not surgical candidates

37
Q

What is the first-line treatment for SCLC?

A

Cisplatin + etoposide + XRT (radiation)

for palliative treatment:
-Carboplatin/etoposide + atezolizumab (or durvalumab, PD-L1 inhibitors); PD-1 have not worked that well